Ramaphosa to attend announcement by Dr Patrick Soon-Shiong of launch of NantAfrica Covid-19 and cancer vaccine

President Cyril Ramaphosa will be the guest of honour today, Thursday, 23 September 2021, at an announcement by Dr Patrick Soon-Shiong, founder of the multinational conglomerate, NantWorks LLC, of an initiative ambitious initiative to build capacity for advanced health care in Africa.

The initiative will entail collaboration among NantAfrica, the Council for Scientific and Industrial Research (CSIR), the South African Medical Research Council (SAMRC), the Centre for Epidemic Response and Innovation (CERI), and the universities of Cape Town, Witwatersrand, Stellenbosch and KwaZulu-Natal.

NantWorks is a multinational, California-based conglomerate that is leading the digital revolution in healthcare, technology and media through the harnessing of science, digital infrastructure, supercomputing and communication.

NantWorks LLC has signed a collaboration agreement with the CSIR and the SAMRC that will initiate the transfer of biologic manufacturing technology for COVID-19 and cancer vaccines and next-generation cell-based immunotherapies.

This will enable the rapid clinical development of next generation vaccines for infectious diseases and cancer at centres of excellence across the country.

News date: 2021-09-23



KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).

Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira